183 related articles for article (PubMed ID: 28937055)
1. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients.
Atageldiyeva KK; Nemr R; Echtay A; Racoubian E; Sarray S; Almawi WY
Gene; 2019 Oct; 715():144011. PubMed ID: 31357022
[TBL] [Abstract][Full Text] [Related]
3. Apo E gene polymorphism on development of diabetic nephropathy.
Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
[TBL] [Abstract][Full Text] [Related]
4. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan.
Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ
J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotyping in Egyptian diabetic nephropathy patients.
Atta MI; Abo Gabal K; El-Hadidi K; Swellam M; Genina A; Zaher NF
IUBMB Life; 2016 Jan; 68(1):58-64. PubMed ID: 26662731
[TBL] [Abstract][Full Text] [Related]
6. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
[TBL] [Abstract][Full Text] [Related]
7. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy.
Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C
J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737
[TBL] [Abstract][Full Text] [Related]
8. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
Roussos L; Ekström U; Ehle PN; Oqvist B; Floren CH
Scand J Urol Nephrol; 2004; 38(6):504-10. PubMed ID: 15841787
[TBL] [Abstract][Full Text] [Related]
10. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy.
Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J
Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716
[TBL] [Abstract][Full Text] [Related]
11. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus.
Ha SK; Park HS; Kim KW; Kim SJ; Kim DH; Kim JH; Lee HY; Han DS
Nephrol Dial Transplant; 1999 Sep; 14(9):2144-9. PubMed ID: 10489223
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphic gene markers of lipid metabolism are associated with diabetic nephropathy in patients with type 1 diabetes mellitus].
Iakunina NIu; Shestakova MV; Voron'ko OE; Vikulova OK; Sevost'ianov KV; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
Genetika; 2005 Jul; 41(7):931-7. PubMed ID: 16152798
[TBL] [Abstract][Full Text] [Related]
14. Effects of Apolipoprotein E Isoforms in Diabetic Nephropathy of Chinese Type 2 Diabetic Patients.
Jiang Y; Ma L; Han C; Liu Q; Cong X; Xu Y; Zhao T; Li P; Cao Y
J Diabetes Res; 2017; 2017():3560920. PubMed ID: 28326331
[TBL] [Abstract][Full Text] [Related]
15. Association of the angiotensinogen M235T and APO E gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
Reis KA; Ebinç FA; Koç E; Demirci H; Erten Y; Güz G; Derici UB; Bali M; Söylemezoğlu O; Arınsoy T; Sindel S
Ren Fail; 2011; 33(5):469-74. PubMed ID: 21500980
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism and expression in type 2 diabetic patients with nephropathy: clinicopathological correlation.
Guan J; Zhao HL; Baum L; Sui Y; He L; Wong H; Lai FM; Tong PC; Chan JC
Nephrol Dial Transplant; 2009 Jun; 24(6):1889-95. PubMed ID: 19218599
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in the Chinese from Shanghai.
Shen X; Xia Y; Sass C; Visvikis S; Siest G
Clin Chem Lab Med; 1998 Aug; 36(8):615-9. PubMed ID: 9806471
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.
Li Y; Tang K; Zhang Z; Zhang M; Zeng Z; He Z; He L; Wan C
Mol Biol Rep; 2011 Jun; 38(5):3243-52. PubMed ID: 20177792
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients.
Morbois-Trabut L; Chabrolle C; Garrigue MA; Lasfargues G; Lecomte P
Diabetes Metab; 2006 Jun; 32(3):270-5. PubMed ID: 16799405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
